Effects of Vigiis 101-LAB on a healthy population's gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study

Vigiis 101-LAB capsules are produced from the fermentation of Lactobacillus paracasei subsp. paracasei NTU 101. We tested effects of Vigiis 101-LAB capsules I or II (5 or 10 billion CFU/day, respectively) on gut microflora in clinical trial I, and on peristalsis, immunity, and anti-oxidative capacit...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 6; no. 9; p. e04979
Main Authors Chen, Chien-Li, Liou, Jyh-Ming, Lu, Tsong-Ming, Lin, Yi-Hsien, Wang, Chin-Kun, Pan, Tzu-Ming
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2020
Elsevier
Subjects
Online AccessGet full text
ISSN2405-8440
2405-8440
DOI10.1016/j.heliyon.2020.e04979

Cover

More Information
Summary:Vigiis 101-LAB capsules are produced from the fermentation of Lactobacillus paracasei subsp. paracasei NTU 101. We tested effects of Vigiis 101-LAB capsules I or II (5 or 10 billion CFU/day, respectively) on gut microflora in clinical trial I, and on peristalsis, immunity, and anti-oxidative capacity in clinical trial II, during a 4-week randomized, double-blind, placebo-controlled, adaptive-design study. In trial I, 36 subjects were divided into capsule I and placebo groups. After 4 weeks, Bifidobacterium spp. and Lactobacillus spp. counts were significantly higher in the feces of treatment subjects, with increases of 4.01- and 4.25-fold, respectively. In trial II, 52 subjects were divided into capsule II and placebo groups. After 4 weeks, the treatment group was found to have improved motility, decreased food transit time, and significantly increased immunoglobulin G, immunoglobulin M, and antioxidant activity. Thus, daily administration of Vigiis 101 capsule II can improve peristalsis, immunity, and anti-oxidative capacity. Microbiology; Food microbiology; Nutrition; Evidence-based medicine; Gut microflora; Immunity; Anti-oxidative capacity; Lactobacillus paracasei subsp. paracasei NTU 101; Probiotics
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These two authors contributed equally to this work.
ISSN:2405-8440
2405-8440
DOI:10.1016/j.heliyon.2020.e04979